News About: R&D


KDRA & KIRAMS sign ‘New Drug Development Agreement’

The Korea Drug Research Association(Chairman Dong-Yeon Kim, KDRA) and the Korea Institute of Radiological & Medical Sciences’(KIRAMS) Advanced Concept Medical Technology Development Platform Building Project Team(Team...

‘Remote dispenser’ completed with examination, to be introduced to vice ministers’ meeting

The Office of Legislation’s examination for remote drug dispensers was finished. Their name was officially finalized as ‘Video Drug Vending Machine.’ According to the Ministry of Health and Welfare(MFDS), the Office ...

Alteogen challenges to KRW 2 trillion hemophilia biomedicine ‘NovoSeven’

Alteogen Inc.(CEO Soon-Jae Park) held an agreement ceremony on the 29th of November as its long-acting hemophilia treatment being developed, ‘ALT-Q2,’ was selected as a project to develop a substance candidate for a p...

Nature Cell acquires approval of Phase 1/2 clinical trials for dementia treatment from US FDA

Clinical trials to treat American Alzheimer’s disease patients with stem cells manufactured in Korea were approved by the U.S. FDA. Nature Cell(CEO Jung-Chan La) announced it acquired approval of the Astrostem’s Phas...

Development trend in modified drugs, ‘complex antidiabetics’

The Korean pharmaceutical companies’ development trend of modified drugs was analyzed as development of complex antidiabetics. According to the Ministry of Food and Drug Safety’s Online Drug Library, the number of dr...

What are vaccines to keep eye on for shingles?

The number of shingles patients has been increasing, and most of them are actually the middle-aged and elders. Thus, companies actively developing vaccines seem to be busy proving rate of prevention in the elder group...

“Once remote medicine dispensers are implemented, they will eventually be managed by call centers”

“If the door of remote medicine dispenser opens, the function of pharmacists will be destroyed. Even though there will be lots of restrictions soon, it will be spoiled in various forms through future law amendments, w...

Clear opinion differences between Sanofi vs LG over ‘Zemiglo’

The outline of the lawsuit over ‘Zemiglo,’ an antidiabetic developed by LG Life Sciences, became visible.   The first defense for the damage suit filed by the previous seller of Zemiglo, Sanofi-Aventis Korea, against...

Multiple myeloma therapy, ‘Kyprolis’ conducted Phase 3 clinical trials on Koreans

The new multiple myeloma therapy, ‘Kyprolis(carfilzomib, Amgen),’ will start a Phase 3 clinical trial adding 16 Korean subjects. It has attracted interests of the industry since it is a newly-approved clinical trial ...

Next-generation dementia therapy’s Phase 3 clinical trials starts in Korea

The next generation dementia therapy, which was expected to generate approximately KRW 1 trillion prescriptions in the global market, was approved to conduct Phase 3 clinical trials in Korea. The therapy is ‘RVT-101’...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.